feed,title,long_url,short_url
Benzinga,"BioNTech, Regeneron To Evaluate FixVac-Based Cancer Vaccine/Libtayo Combo In NSCLC",https://benzinga.com/general/biotech/22/03/26039960/biontech-regeneron-to-evaluate-fixvac-based-cancer-vaccinelibtayo-combo-in-nsclc,https://bit.ly/3sRVZSO
